Skip to main content
Get Alerts

Imprimis NJOF, LLC

Recalls

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20211
20233
202410
20254
20263
Download CSV

FDA Recall Ongoing 2026 recordClass II

Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852. NDC 71384-746-06.

by Imprimis NJOF, LLC

Reason
Presence of particulate matter - Glass like particles.
Published
January 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Dexamethasone Moxifloxacin Ketorolac, 1 mg/mL, 0.5 mg/mL, 0.4 mg/mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-513-01.

by Imprimis NJOF, LLC

Reason
Presence of particulate matter - Glass like particles.
Published
January 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1

by Imprimis NJOF, LLC

Reason
Presence of particulate matter - Glass like particles.
Published
January 14, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Klarity-C Drops (Cyclosporine) 0.1%, Preservative-Free Sterile Ophthalmic Emulsion, This is a compounded drug, Office Use Only, 5.5 mL bottle, Rx only, Mfg by: Imprimis NJOF, LLC, 1705 Route 46 West, Ledgewood, NJ 07852, NDC 71384-514-05

by Imprimis NJOF, LLC

Reason
Subpotent Drug
Published
November 26, 2025
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass III

Tropicamide-Proparacaine-Phenylephrine-Ketorolac, Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5mL, 2x5ML vial per carton, Rx Only, Imprimis NJOF, LLC, 1705 Route 46 West, Unit 6B, Ledgewood, NJ 07852, NDC 71384-733-05.

by Imprimis NJOF, LLC

Reason
Sub-Potent Drug: Subpotent assay results during stability testing.
Published
July 30, 2025
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Epinephrine Lidocaine HCL, 0.25mg/mL and 7.5 mg/mL, 20x1 mL Vials per carton, Rx Only, Imprimis NJOF, 1705 Route 46 West, Unit 6B Ledgewood, NJ, 07852 NDC: 71384-641-01

by Imprimis NJOF, LLC

Reason
Sub-Potent Drug: Subpotent assay results during stability testing.
Published
July 30, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution, 1% 0.5% 2.5% 0.5%, 5 mL fill in 15 mL bottle, Imprimis NJOF, LLC, Route 46 West, Unit 6B, Ledgewood, NJ, 07852, NDC: 71384-733-05.

by Imprimis NJOF, LLC

Reason
Sub-Potent Drug: The stability batch showed a subpotent result, which does not meet the product specifications of 90.0-110.0% of the label claim.
Published
April 9, 2025
Distribution
FL and NY

View recall →

FDA Recall Ongoing Historical recordClass II

Prednisolone-Moxifloxacin-Bromfenac Sterile Ophthalmic Suspension, 1%, 0.5%, 0.075%, 5mL, Quantity: 20mL, Rx Only, Compounded by: Imprimis NJOF, LLC. 1705 Route 46 West, Unit 6B Ledgewood, NJ NDC 71384-310-05

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Published
June 19, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Klarity-C (cyclosporine) Preservative-Free Sterile Ophthalmic Emulsion 0.1% 5.5mL, Rx Only, This is a compounded drug. NOT FOR RESALE. OFFICE USE ONLY Compounded by: Imprimis NJOF, LLC., 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852 NDC: 71384-514-05

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Published
June 19, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL Single-Use vial for Intraocular Injection, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-640-01

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Published
June 5, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Moxifloxacin 4 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-511-08

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Published
June 5, 2024
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for Intraocular Injection, Rx only, Imprimis NJOF, LLC. 1705 Route 46 West, unit 6B, Ledgewood, NJ 07852, NDC 71384-509-08

by Imprimis NJOF, LLC

Reason
Lack of Assurance of Sterility
Published
June 5, 2024
Distribution
Nationwide

View recall →

This page lists recalls that name Imprimis NJOF, LLC as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.